Literature DB >> 19267387

Is there an indication for initial conservative management of pancreatic cystic lesions?

Stephen R Grobmyer1, William G Cance, Edward M Copeland, Stephen B Vogel, Steven N Hochwald.   

Abstract

BACKGROUND: The management of small pancreatic cystic lesions presents a clinical challenge.
METHODS: We reviewed our experience with 78 patients who presented with a cystic pancreatic lesion who underwent operative management between 1995 and 2005. Data on cyst characteristics were analyzed in the context of pathologic findings following resection.
RESULTS: Among 78 patients, there were 55 (71%) females; median age 63 years. Patients presented with: an incidental finding (48%), pain (40%), acute pancreatitis (4%), other (8%). Operations were distal pancreatectomy (n = 47), pancreaticoduodenectomy (n = 16), and other (n = 15). Most patients had a non-malignant lesion (n = 65, 83%) (mucinous cystadenoma (n = 29), serous cystadenoma (n = 15), IPMN without invasion (n = 8), pseudocyst (n = 8), other benign (n = 5)). Malignant lesions (adenocarcinoma, neuroendocrine tumor, and other) were found in 13 patients (17%). The risk of malignancy increased with size: <3 cm (n = 25), 4%; 3-5 cm (n = 23), 13%; and >5 cm (n = 30), 30%. Pre-operative cyst fluid cytology was performed in 41 patients. The negative predictive value (NPV) of cytology for malignancy was 88% and the positive predictive value (PPV) was 80%. The NPV of CA 19-9 for malignancy was 90%; the PPV was 50%.
CONCLUSIONS: Initial conservative management of small cystic pancreatic lesions may be indicated in selected patients. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19267387     DOI: 10.1002/jso.21260

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  7 in total

Review 1.  To cease or 'de-cyst'? The evaluation and management of pancreatic cystic lesions.

Authors:  Brintha K Enestvedt; Nuzhat Ahmad
Journal:  Curr Gastroenterol Rep       Date:  2013-10

2.  Natural history of asymptomatic pancreatic cystic neoplasms.

Authors:  Gareth Morris-Stiff; Gavin A Falk; Sricharan Chalikonda; R Matthew Walsh
Journal:  HPB (Oxford)       Date:  2012-07-23       Impact factor: 3.647

3.  From Acute Pancreatitis to Stage IV Pancreatic Cancer in 12 Weeks.

Authors:  Chijioke Enweluzo; Simanta Dutta; Fahad Aziz; Stephen Lenfest
Journal:  Case Rep Gastroenterol       Date:  2013-07-13

4.  Serum Carbohydrate Antigen 19-9 in Differential Diagnosis of Benign and Malignant Pancreatic Cystic Neoplasms: A Meta-Analysis.

Authors:  Shaobo Cao; Ya Hu; Xiang Gao; Quan Liao; Yupei Zhao
Journal:  PLoS One       Date:  2016-11-11       Impact factor: 3.240

Review 5.  Potential prognostic biomarkers in pancreatic juice of resectable pancreatic ductal adenocarcinoma.

Authors:  Shefali Agrawal
Journal:  World J Clin Oncol       Date:  2017-06-10

6.  Management of Patients With Pancreatic Cysts: Analysis of Possible False-Negative Cases of Malignancy.

Authors:  Thomas Kowalski; Ali Siddiqui; David Loren; Howard R Mertz; Damien Mallat; Nadim Haddad; Nidhi Malhotra; Brett Sadowski; Mark J Lybik; Sandeep N Patel; Emuejevoke Okoh; Laura Rosenkranz; Michael Karasik; Michael Golioto; Jeffrey Linder; Marc F Catalano; Mohammad A Al-Haddad
Journal:  J Clin Gastroenterol       Date:  2016-09       Impact factor: 3.062

7.  Influence of integrated molecular pathology test results on real-world management decisions for patients with pancreatic cysts: analysis of data from a national registry cohort.

Authors:  David Loren; Thomas Kowalski; Ali Siddiqui; Sara Jackson; Nicole Toney; Nidhi Malhotra; Nadim Haddad
Journal:  Diagn Pathol       Date:  2016-01-20       Impact factor: 2.644

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.